Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras

Area of Science:

• Immunology
• Hematology
• Genetics

Background:

• Severe combined immunodeficiency (SCID) is a group of genetic disorders causing profound immune deficiencies.
• Bone marrow transplantation (BMT) is a curative treatment for SCID, restoring T-cell function.
• Previous studies showed T-cell reconstitution and diversity for up to 10 years post-BMT.

Purpose of the Study:

• To assess the long-term fate of thymic function and T-cell repertoire diversity in SCID patients more than 10 years after BMT.
• To evaluate the durability of immune reconstitution following nonablative BMT in SCID.
• To determine if T-cell function and diversity are maintained long-term after BMT for SCID.

Main Methods:

• Long-term follow-up study of 128 SCID patients.
• Analysis of T-cell function, thymic output, and T-cell receptor diversity.
• Study included patients with 11 different molecular types of SCID.
• Nonablative bone marrow transplantation (BMT) was performed.

Main Results:

• T-cell function, thymic output, and T-cell clonal diversity are maintained long-term (over 25 years) after BMT in SCID patients.
• Evidence of sustained thymic function and a diverse T-cell repertoire was observed.
• Results indicate the long-term efficacy of BMT in restoring and maintaining immune competence.

Conclusions:

• Nonablative BMT provides durable immune reconstitution in SCID patients.
• Thymic function and T-cell diversity are preserved for over 25 years post-transplantation.
• This study confirms the long-term benefits of BMT for SCID, supporting its role as a curative therapy.